Guide tactical decisions.
Navigating tactical decisions to pull through your strategy.
What we do.
We translate strategy into the tactical decisions that drive measurable results.
This service connects commercialization & growth, value, pricing & access strategy, evidence generation, and change management – ensuring strategic intent is realized through execution. We align R&D, clinical, and commercial pathways, shape pricing, access, and contracting approaches, generate and apply evidence to meet payer and regulatory needs, and enable teams to adopt new ways of working.
By linking science, strategy, and implementation, we help clients accelerate adoption, enhance performance, and maximize the value of their investments across the product lifecycle.
Insights & latest.
Access the most up-to-date health and life sciences insights and resources.
-
Thought LeadershipRead more
Why Real-World External Control Arms Are Gaining Ground in Health Technology Assessment
Discover how real-world external control arms (RW-ECAs) provide robust comparative evidence for HTA submissions when RCTs are impractical or unethical
-
Thought LeadershipRead more
Unlocking Patient Insights in HEOR Through Netnography: A Scalable Qualitative Research Method
In pharma commercialization, AI and analogs set the stage, but human insight drives strategies that break precedent and win markets
-
Thought LeadershipRead more
AI as the Input, Not the Answer: When Human Strategy Still Leads
In pharma commercialization, AI and analogs set the stage, but human insight drives strategies that break precedent and win markets
-
Thought LeadershipRead more
Refining the Parallels Between EMA Expansion and JCA Implementation: Quantitative Insights and Recommendations
Parallels between EMA & JCA reveal risks of imbalance in EU HTA. Learn how to ensure fair, inclusive JCA implementation.
Connect.
Let’s discuss how we can help you.